Faculty Opinions recommendation of Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme.

Pooled Data ◽

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dky204 ◽

2018 ◽

Vol 73 (9) ◽

pp. 2519-2523 ◽

Cited By ~ 21

Author(s):

Gregory G Stone ◽

Paul Newell ◽

Leanne B Gasink ◽

Helen Broadhurst ◽

Angela Wardman ◽

...

Keyword(s):

Clinical Trial ◽

Pseudomonas Aeruginosa ◽

Phase Iii ◽

Clinical Activity ◽

Pooled Data ◽

Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme

Drug Safety ◽

10.1007/s40264-020-00934-3 ◽

2020 ◽

Vol 43 (8) ◽

pp. 751-766

Author(s):

Karen Cheng ◽

Paul Newell ◽

Joseph W. Chow ◽

Helen Broadhurst ◽

David Wilson ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Safety Profile ◽

Phase Iii ◽

Pooled Data ◽

Adult Phase ◽

Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial

Neurological Research ◽

10.1080/01616412.2020.1711648 ◽

2020 ◽

Vol 42 (4) ◽

pp. 286-290 ◽

Cited By ~ 1

Author(s):

Yi Dong ◽

Jiazhi Qu ◽

Zhijun Zhang ◽

Changjun Wang ◽

Qiang Dong

Keyword(s):

Clinical Trial ◽

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Phase Iii ◽

Stroke Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Pooled Data

Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme

Diabetes Obesity and Metabolism ◽

10.1111/dom.12624 ◽

2016 ◽

Vol 18 (4) ◽

pp. 419-424 ◽

Cited By ~ 14

Author(s):

M. Yu ◽

K. Van Brunt ◽

O. J. Varnado ◽

K. S. Boye

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Patient Reported Outcome ◽

Phase Iii ◽

Patient Reported ◽

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta‐analysis of the liraglutide phase III clinical trial programme

Diabetes Obesity and Metabolism ◽

10.1111/dom.12617 ◽

2016 ◽

Vol 18 (7) ◽

pp. 707-710 ◽

Cited By ~ 4

Author(s):

E. Montanya ◽

V. Fonseca ◽

S. Colagiuri ◽

L. Blonde ◽

M. Donsmark ◽

...

Keyword(s):

Clinical Trial ◽

Body Mass Index ◽

Body Mass ◽

Meta Analysis ◽

Glycated Haemoglobin ◽

Phase Iii ◽

Baseline Body Mass Index ◽

NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease

PsycEXTRA Dataset ◽

10.1037/e607462007-001 ◽

2007 ◽

Keyword(s):

Parkinson’S Disease ◽

Clinical Trial ◽

Parkinson's Disease ◽

Phase Iii ◽

Phase Iii Clinical Trial

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Faculty Opinions recommendation of Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725828169.793561106 ◽

2019 ◽

Author(s):

Mark Bower

Keyword(s):

Clinical Trial ◽

Kaposi's Sarcoma ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Kaposi’S Sarcoma ◽

Phase Iii ◽

Phase Iii Clinical Trial

Faculty Opinions recommendation of A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727289372.793551519 ◽

2018 ◽

Author(s):

Adil Bharucha

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Idiopathic Constipation ◽

Chronic Idiopathic Constipation

Faculty Opinions recommendation of A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727289372.793528809 ◽

2017 ◽

Author(s):

Aldo Infantino

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Idiopathic Constipation ◽

Chronic Idiopathic Constipation